Beyond Medical Technologies Stock Return On Equity
| DOCKF Stock | USD 0.07 0.00 0.00% |
Beyond Medical Technologies fundamentals help investors to digest information that contributes to Beyond Medical's financial success or failures. It also enables traders to predict the movement of Beyond Stock. The fundamental analysis module provides a way to measure Beyond Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Beyond Medical stock.
Beyond |
Beyond Medical Technologies Company Return On Equity Analysis
Beyond Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Beyond Medical Return On Equity | -1.89 |
Most of Beyond Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beyond Medical Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Beyond Medical Technologies has a Return On Equity of -1.8854. This is 528.5% lower than that of the Machinery sector and 41.08% lower than that of the Industrials industry. The return on equity for all United States stocks is notably higher than that of the company.
Beyond Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beyond Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Beyond Medical could also be used in its relative valuation, which is a method of valuing Beyond Medical by comparing valuation metrics of similar companies.Beyond Medical is currently under evaluation in return on equity category among its peers.
Beyond Fundamentals
| Return On Equity | -1.89 | ||||
| Return On Asset | -3.8 | ||||
| Current Valuation | 1.69 M | ||||
| Shares Outstanding | 15.81 M | ||||
| Shares Owned By Insiders | 5.57 % | ||||
| Price To Earning | 38.84 X | ||||
| Price To Book | 17.94 X | ||||
| Price To Sales | 1.41 X | ||||
| Gross Profit | (250.49 K) | ||||
| EBITDA | (773.19 K) | ||||
| Net Income | (595.96 K) | ||||
| Cash And Equivalents | 877.31 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 30 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.73 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (527.04 K) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 27.98 | ||||
| Beta | 6111.09 | ||||
| Market Capitalization | 1.67 M | ||||
| Total Asset | 95.64 K | ||||
| Retained Earnings | (26.1 M) | ||||
| Working Capital | (334.72 K) | ||||
| Net Asset | 95.64 K |
About Beyond Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beyond Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:Check out Beyond Medical Piotroski F Score and Beyond Medical Altman Z Score analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.